참고문헌
- Agrawal N, Naithani R, Mahapatra M, et al (2007). Chronic lymphocytic leukemia in India - a clinico-haematological profile. Hematology, 12, 229-33. https://doi.org/10.1080/10245330701255064
- D'Arena G, Tarnani M, Rumi C, et al (2007). Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol, 82, 787-91. https://doi.org/10.1002/ajh.20936
- Dodhy MA, Zafar H, Aslam W (2011). Chronic Lymphocytic Leukemia: an Experience of a decade at a Tertiary Care Hospital. Ann Pak Inst Med Sci, 7, 196-9.
- Ehsan A, Lone A, Khan MA (2013). Autoimmune complications in chronic lymphocytic leukemia: a single center experience. Biomedica, 29, 37-41.
- Ghosh J, Singh RK, Saxena R, et al (2013). Prevalence and aetiology of anaemia in lymphoid malignancies. Natl Med J India, 26, 79-81.
- Gogia, A. Sharma, V. Raina, et al (2011). Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia. J Clin Oncol, 29, 2011. https://doi.org/10.1200/JCO.2010.33.5091
- Gribben JG (2008). Molecular profiling in CLL. Hematology Am Soc Hematol Educ Program. 2008, 444-9. https://doi.org/10.1182/asheducation-2008.1.444
- Hamblin TJ (2007). Prognostic markers in chronic lymphocytic leukaemia. Best Pract Res Clin Haematol, 20, 455-68. https://doi.org/10.1016/j.beha.2007.02.001
- Idris M, Shah SH, Fareed J, Gul N (2004). An experience with sixty cases of haematological malignancies; a clinico haematological correlation. J Ayub Med Coll Abbottabad, 16, 51-4.
- Kawamata N, Moreilhon C, Saitoh T, et al (2013). Genetic differences between Asian and Caucasian chronic lymphocytic leukemia. Int J Oncol, 43, 561-5.
- Kermani IA, Dehdilani M, Dolatkhah R (2007). Chronic lymphocytic leukemia in the recent 10 years and treatment effects of fludarabin. Asian Pac J Cancer Prev, 8, 367-71.
- Khan M, Saif A, Sandler S, Mirrakhimov AE (2014). Idelalisib for the treatment of chronic lymphocytic leukemia. ISRN Oncol, 2014, 931858.
- Khalid A, Zahid M, Rehman A, et al (1997). Clinicoepidemiological features of adult leukemias in Pakistan. Pak Med Assoc, 47, 119-22.
- Li ZJ, Qiu LG, Wu T, et al (2008). The clinical and laboratory features of 263 cases of chronic lymphocytic leukemia. Zhonghua Xue Ye Xue Za Zhi, 29, 300-3.
- Maurer C, Hallek M (2013). Chronic lymphocytic leukemia. Dtsch Med Wochenschr, 138, 2153-66. https://doi.org/10.1055/s-0033-1349491
- Mozaheb Z, Hasanzadeh NazarAbadi MH, Aghaee MA (2012). Chronic lymphocytic leukemia and prognostic factors. Asian Pac J Cancer Prev, 13, 3009-13. https://doi.org/10.7314/APJCP.2012.13.7.3009
- Mukiibi JM, Paul B, Nyirenda CM, et al (2004). Chronic lymphocytic leukaemia (CLL) in Central Africans. Cent Afr J Med, 50, 111-5.
- Omoti CE, Awodu OA, Bazuaye GN (2007).Chronic lymphoid leukaemia: clinico-haematological correlation and outcome in a single institution in Niger Delta region of Nigeria. Int J Lab Hematol, 29, 426-32. https://doi.org/10.1111/j.1751-553X.2007.00888.x
- Qi RJ, Zhang PH, Qiu LG, et al (2009). Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma. Zhonghua Bing Li Xue Za Zhi, 38, 329-32.
- Rafiq N, Iqbal T, Shahid M, Muhammad F (2014). Hematological and biochemical parameters in Pakistani chronic lymphoblastic leukemia patients. Pak J Life Soc Sci, 12, 16-19.
- Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL (2004). The clinical and epidemiological burden of chronic lymphocytic leukaemia. Eur J Cancer Care Engl, 13, 279-87. https://doi.org/10.1111/j.1365-2354.2004.00489.x
- Sagatys EM, Zhang L (2012). Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia. Cancer Control, 19, 18-25.
- Salawu L, Bolarinwa RA, Durosinmi MA (2010). Chronic lymphocytic leukaemia: a-twenty-years experience and problems in Ile-Ife, South-Western Nigeria. Afr Health Sci, 10, 187-92.
- Sriphatphiriyakun T, Auewarakul CU (2005). Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective analysis of 184 cases. Asian Pac J Allergy Immunol, 23, 197-203.
- Tjonnfjord GE, Ly BE, Johannesen TB, et al (2012). Chronic lymphocytic leukaemia in Norway--incidence and prognostic markers at diagnosis. Tidsskr Nor Laegeforen, 132, 2056-9. https://doi.org/10.4045/tidsskr.11.1349
- Vroblova V, Smolej L, Vrbacky F, et al (2009). Biological prognostic markers in chronic lymphocytic leukemia. Acta Medica Hradec Kralove, 52, 3-8.
피인용 문헌
- Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells vol.13, pp.1, 2015, https://doi.org/10.3892/mmr.2015.4600
- Serum 25-hydroxyvitamin D Insufficiency in B-Chronic Lymphoid Leukemia at the Time of Disease Presentation in Pakistan vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5983
- Direct Coombs Test Positivity in B-Chronic Lymphoid Leukemia: a Marker of Advanced Clinical Disease vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.6007